FdaApplication

NDA 021951

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSUN PHARMACEUTICAL INDUSTRIES INC
application_typeNDA
approval_date2012-05-25

Products (6)

ProductActive ingredientStrengthDosage form
ABSORICAISOTRETINOIN35MGCAPSULE;ORAL
ABSORICAISOTRETINOIN25MGCAPSULE;ORAL
ABSORICAISOTRETINOIN10MGCAPSULE;ORAL
ABSORICAISOTRETINOIN40MGCAPSULE;ORAL
ABSORICAISOTRETINOIN30MGCAPSULE;ORAL
ABSORICAISOTRETINOIN20MGCAPSULE;ORAL

6 products